InsiderTrades

Form 4 for ANIP ANI PHARMACEUTICALS INC

Accepted 2023-10-19 00:00:00 ET · period of report 2023-10-17 · accession 0001870913-23-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2023-10-19 2023-10-17+ ANIP Shanmugam Muthusamy HEAD OF R, D, COO-NOVITIUM OPS, Dir S - Sale $57.75 -25.0K 1.05M -2% -$1.44M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-10-18 S D 6,242 $57.78 1,042,620 I Held by Esjay LLC — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.15 to $58.41, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
2 Common Common Stock 2023-10-19 S D 10,000 $57.06 1,032,620 I Held by Esjay LLC — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.69, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
3 Common Common Stock 2023-10-17 S D 8,758 $58.53 1,048,862 I Held by Esjay LLC — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $58.03 to $59.47, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.